ESR1 and breast cancer: The role of the estrogen receptor (ER) in breast cancer has been well elucidated, and estrogen blockade using selective estrogen receptor modulators (SERMs) and aromatase inhibitors is fundamental in breast cancer therapeutics [1, 2].